logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Niven Mehra

radboud universitair medisch centrum
H指数:45
被引数:9,198

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Non-BRCA Mutation Subgroup of Patients with Metastatic Castration-resistant Prostate Cancer in the PROpel Trial

在PROpel试验中，奥拉帕利联合阿比特龙与安慰剂联合阿比特龙治疗转移性去势抵抗性前列腺癌非BRCA突变亚组患者的有效性与安全性比较

European Urology Oncology
IF9.3
2026-10-050
OAAI
Niven Mehra; Noel W. Clarke; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Emma Brown; Jae Young Joung; Mikio Sugimoto; Young Deuk Choi; Daniel Castellano; Yüksel Ürün; Christian Hosius; David McGuinness; Arnold Degboe; Fred Saad
Exploration of tumor genomics associated with prolonged benefit from or resistance to talazoparib monotherapy in patients with metastatic castration-resistant prostate cancer

探索与转移性去势抵抗性前列腺癌患者从talazoparib单药治疗中获益延长或耐药相关的肿瘤基因组学研究

European Journal of Cancer
IF7.1
2026-09-290
OA
Elena Castro; A. Douglas Laird; Niven Mehra; Tanya Dorff; Song Zhao; Inge van Oort; Donatello Gasparro; Fabio Calabrò; Sandro Pignata; Lajos Geczi; Philippe Barthélémy; Deepak Kilari; Ryon P. Graf; Hsiang-Chun Chen; Cynthia G. Healy; Giorgio V. Scagliotti; Jijumon Chelliserry; Dana Kennedy; Karim Fizazi; Johann S. de Bono
Radium-223 decreases PD-L1 expression in bone metastases: A study with [89Zr]Zr-atezolizumab PET and immunohistological correlation

镭-223降低骨转移中PD-L1的表达：一项基于[89Zr]Zr-阿特珠单抗PET和免疫组化相关性的研究

European Journal of Nuclear Medicine and Molecular Imaging
IF7.6
2026-09-120
OAAI
Sui Wai Ling; Anouk de Jong; Mark Gorris; Marcel Segbers; Laura Graven; Marjolein van Driel; Geert van Leenders; Khrystany Isebia; Marjolijn Lub – de Hooge; Paul Hamberg; Niven Mehra; Mandy van Brakel; Ronald de Wit; Reno Debets; Elisabeth de Vries; Tessa Brabander; Jolanda de Vries; Astrid van der Veldt
From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

从基因组检测到奥拉帕利治疗：BRCA突变的转移性去势抵抗性前列腺癌的真实世界应用与结局

DRUGS-REAL WORLD OUTCOMES
IF1.9
2026-06-010
OA
Bosch, Dianne; van der Velden, Kim J. M.; Beeker, Aart; van den Berg, Hendrik P.; Bergman, Andre M.; van der Doelen, Maarten J.; van den Eertwegh, Alfons J. M.; Hendriks, Mathijs P.; Kerkhofs, Thomas M. A.; van de Luijtgaarden, Addy C. M.; Mehra, Niven; van Moorselaar, Reindert J. A.; Tascilar, Metin; Vervenne, Walter L.; Weijl, Nir I.; Uyl-de Groot, Carin A.; Mulders, Peter F. A.; Kuppen, Malou C. P.; van Oort, Inge M.
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression

EMETPRO：一项多中心、国际性回顾性分析，评估早期进展的转移性激素敏感性前列腺癌患者

Prostate Cancer and Prostatic Diseases
IF5.8
2026-05-290
PRE
Fabio Turco; Silke Gillessen; Giuseppe Salfi; Iris S. H. Kloots; Peter H. J. Slootbeek; Niven Mehra; Matthew Labriola; Daniel J. George; Amanda Broderick; Anna Patrikidou; Hortense Patry; Consuelo Buttigliero; Veronica Crespi; Hirotsugu Uemura; Kazutoshi Fujita; Takanobu Utsumi; Hiroyoshi Suzuki; Daniele Raggi; Umberto Basso; Rafael Morales-Barrera; David Marmolejo Castaneda; Cora N. Sternberg; Daniela Guevara; Orazio Caffo; Giuseppe Procopio; Andrea Zivi; Sara Merler; Mariella Sorarù; Daniel E. Spratt; Pedro C. Barata; Carlo Messina; Yüksel ürün; Hatice Bolek; Ignacio Duràn; Juan Diego Cacho Lavin; Nieves Martínez Chanzá; Lisa G. Horvath; Rhiannon Mellor; Levent Türkeri; Merve Bengisu Soykök; Sabrina Rossetti; Richard Cathomas; Giuseppe Luigi Banna; Vincenza Conteduca; Margaret Ottaviano; Laura Marandino; Hui-Ming Lin; Luigi Tortola; Ricardo Pereira Mestre; Martino Pedrani
[177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study

[177Lu]-PSMA-617-PSMA-617 在寡转移性激素敏感性前列腺癌中的研究（BULLSEYE）：一项开放标签、随机、II期研究

The Lancet Oncology
IF0
2026-03-300
PRE
Bastiaan M Privé; Walter Noordzij; Constantijn H J Muselaers; Igle J de Jong; Inge M van Oort; Marcel J R Janssen; Maartje C Van Rijk; Willemijn A van Gemert; Bart Timmermans; Michel de Groot; Niven Mehra; Winald R Gerritsen; Marianne A Jonker; Emmanouil Alevroudis; Suzanne van der Gaag; Josephina C C Koppes; J P Michiel Sedelaar; André N Vis; Alexis Vrachimis; Daniela E Oprea-Lager
Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer

前列腺特异性抗原和客观缓解分析在PROpel研究中：奥拉帕利联合阿比特龙对比安慰剂联合阿比特龙作为转移性去势抵抗性前列腺癌的一线疗法

European Urology Oncology
IF9.3
2025-11-040
OAAI
Fred Saad; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Emma Brown; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; Elizabeth A. Harrington; Jinyu Kang; Noel Clarke
Molecular reflex testing in patients with early metastatic castration-resistant prostate cancer within the PROMPT-study

在PROMPT研究中，早期转移性去势抵抗性前列腺癌患者的分子反射测试

British Journal of Cancer
IF6.8
2025-10-310
OA
Iris S. H. Kloots; Peter H. J. Slootbeek; Sofie H. Tolmeijer; Sandra van Wilpe; Minke Smits; Sjoerd van Helvert; Leonie I. Kroeze; Jolique A. van Ipenburg; Katrien Grünberg; C. Marleen Kets; Marjolijn J. L. Ligtenberg; James Nagarajah; Jurgen Fütterer; Joyce M. van Dodewaard; Theo van Voorthuizen; Frederiek Terheggen; Tineke J. Smilde; Jack A. Schalken; Inge M. van Oort; Haiko J. Bloemendal; Winald R. Gerritsen; Niven Mehra
Talazoparib Monotherapy in Metastatic Castration-resistant Prostate Cancer with DNA Damage Response Alterations—Genomic Features Associated with Response to Therapy

Talazoparib单药治疗具有DNA损伤应答改变的转移性去势抵抗性前列腺癌——与治疗反应相关的基因组特征

European Urology Oncology
IF9.3
2025-10-300
PRE
Karim Fizazi; Johann S. de Bono; A. Douglas Laird; Philippe Barthélémy; Rémy Delva; Tanya Dorff; Marco Maruzzo; Adam Stirling; Jean-Pascal Machiels; Herlinde Dumez; Vincent Renard; Julia F. Hopkins; Lee A. Albacker; Hsiang-Chun Chen; Cynthia G. Healy; Liza DeAnnuntis; Jijumon Chelliserry; Inge M. van Oort; Giorgio V. Scagliotti; Niven Mehra
Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer

去势抵抗性前列腺癌中AR位点突变的谱系和临床分级

Annals of Oncology
IF65.4
2025-10-270
OAAI
T. Virtanen; E.M. Kwan; K. Parekh; J.V.W. Bacon; C.F. Huang; I.P.L. Yu; L. Ryyppö; C. Bernales; G. Donnellan; C. Tam; J. Sipola; J. Nikkola; G. Vandekerkhove; S.H. Tolmeijer; K. Kukkonen; null Adelia; B.J. Eigl; D. Finch; R. Gagnon; Y. Takieldeen; E. Hardy; D. Khalaf; C. Kollmannsberger; J.-M. Lavoie; C. Maurice-Dror; S. Miller; L. Nappi; K. Noonan; S. Parimi; A. Riminchan; E. Sartori-Mueller; M. Soleimani; J. Vergidis; M. Zulfiqar; A. Hansen; S. Hotte; M. Jafri; M. Kolinsky; S.D. Mukherjee; M. Ong; A.A.N. Rose; W. Tu; E. Winquist; A.M. Bergman; K. van der Zande; W. Zwart; N. Mehra; N.P. van Erp; J.L. Zhao; D. Rathkopf; C. Barbieri; D. Quigley; M. Nykter; N.A. Lack; K.N. Chi; M. Annala; A.W. Wyatt
Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocol

奥拉帕利用于携带同源重组修复基因突变的肿瘤患者：来自药物再发现方案的结果

International Journal of Cancer
IF4.7
2025-10-160
OAAI
Ilse A. C. Spiekman; Niven Mehra; Laurien J. Zeverijn; Birgit S. Geurts; Karlijn Verkerk; Soemeya F. Haj Mohammad; Vincent van der Noort; Paul Roepman; Wendy W. J. de Leng; Anne M. L. Jansen; Addy C. M. van de Luijtgaarden; Theo van Voorthuizen; Tineke E. Buffart; Hans Gelderblom; Emile E. Voest; Henk M. W. Verheul
Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer

转移性前列腺癌患者中胚系致病性变异的流行率

BJU International
IF4.4
2025-09-020
OAAI
Michiel Vlaming; Wouter Koole; R. Jeroen A. van Moorselaar; Eveline M.A. Bleiker; Ellen van de Geer; Hanneke W.M. van Deutekom; Marjolijn J.L. Ligtenberg; Klaartje van Engelen; C. Marleen Kets; Lizet E. van der Kolk; Gina Schijven; Niven Mehra; M. Arjen Noordzij; Richard P. Meijer; Inge M. van Oort; Lambertus A.L.M. Kiemeney; Margreet G.E.M. Ausems
Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: the NABUCCO trial

局部晚期尿路上皮癌术前伊匹木单抗和纳武利尤单抗的最终临床分析及肿瘤引流淋巴结组成的探索：NABUCCO试验

European Journal of Cancer
IF7.1
2025-08-210
PRE
Chantal F. Stockem; Jeroen van Dorp; Nick van Dijk; Daniel J. Vis; Rolf Harkes; Bram van den Broek; Maartje Alkemade; Annegien Broeks; Kees Hendricksen; Thierry N. Boellaard; Jeantine M. de Feijter; Maurits L. van Montfoort; Antonios Daletzakis; Antoine G. van der Heijden; Richard P. Meijer; Niven Mehra; Lodewyk F.A. Wessels; Bas W.G. van Rhijn; Britt B.M. Suelmann; Michiel S. van der Heijden

研究方向

暂未获取到该数据
I
Inge M. van Oort
H 指数:52论文数:432被引数:1.3万
J
Johann S. de Bono
H 指数:160论文数:2,491被引数:13.5万
W
Winald R. Gerritsen
H 指数:26论文数:147被引数:6,052
J
Jack A. Schalken
H 指数:87论文数:746被引数:2.7万
J
James Nagarajah
H 指数:36论文数:209被引数:4,015
N
Nielka P. van Erp
H 指数:34论文数:281被引数:4,042
D
Diederik M. Somford
H 指数:29论文数:283被引数:4,658
K
Karim Fizazi
H 指数:123论文数:1,539被引数:8.3万
P
Peter H. J. Slootbeek
H 指数:8论文数:20被引数:287
M
Maarten J. van der Doelen
H 指数:11论文数:34被引数:417